BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4427796)

  • 1. [Chemotherapy of tumors based on the principle of partial synchronization of cell proliferation. Preliminary results].
    Jedrzejczak WW; Siekierzyński M; Czarnecki C; Dziuk E; Nowakowski W
    Pol Arch Med Wewn; 1974 Nov; 52(5):473-83. PubMed ID: 4427796
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trials of synchronized attack drug therapy in bronchogenic carcinoma].
    Seccia A; Scafuri L; Scognamillo A; Cocco G
    G Ital Chemioter; 1975; 22(1-2):63-6. PubMed ID: 1235355
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination chemotherapy and radiation therapy in small cell carcinoma of the lung.
    Eagan RT; Maurer LH; Forcier RJ; Tulloh M
    Cancer; 1973 Aug; 32(2):371-9. PubMed ID: 4722918
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
    Curtis JE
    Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
    [No Abstract]   [Full Text] [Related]  

  • 5. Oat cell carcinoma of the lung: combination chemotherapy with cyclophosphamide, vincristine and procarbazine.
    Wittes RE; Hopfan S; Wittes JT; Golbey RB; Martini N
    Clin Bull; 1977; 7(1):21-4. PubMed ID: 212216
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
    Dundalek E
    Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy and radiation therapy for small cell carcinoma.
    Holoye PY; Samuels ML; Lanzotti VJ; Smith T; Barkley HT
    JAMA; 1977 Mar; 237(12):1221-4. PubMed ID: 190427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
    Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
    Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy in bronchogenic carcinoma.
    Ojala A; Nikkanen VN; Palojoki A; Paloheimo S
    Ann Clin Res; 1977 Feb; 9(1):12-4. PubMed ID: 329741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent therapeutic developments in lung cancer.
    Hansen HH; Selawry OS
    Med Ann Dist Columbia; 1971 Sep; 40(9):580-2. PubMed ID: 4939062
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
    Castor H; Fritsch H; Drings P; Moskwa G; von Kaick G
    Med Klin; 1974 Apr; 69(17):750-6. PubMed ID: 4837493
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
    Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma.
    Whitehead RP; Rosenbaum PR; Carbone PP
    Cancer Treat Rep; 1984 May; 68(5):771-3. PubMed ID: 6539171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination chemotherapy in patients with disseminated bronchogenic carcinoma (author's transl)].
    Gropp C; Havemann K; Gassel WD; Hess F; Prignitz R; Schmidt M; Sodomann CP
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977 Dec; 90(3):301-6. PubMed ID: 146331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma.
    Alberto P
    Cancer Chemother Rep 3; 1973 Mar; 4(2):199-206. PubMed ID: 4729321
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy in inoperable lung cancer--a trial of 2 regimens.
    Behera D; Malik SK
    Indian J Chest Dis Allied Sci; 1989; 31(1):21-4. PubMed ID: 2509339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
    Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
    J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
    Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
    Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of ametopterine (MTX) and cyclophosphamide (CPM) based on the principle of partial synchronization of cell proliferation in lung cancer. Phase II study.
    Jedrzejczak WW; Siekierzyński M; Dziuk E; Czarnecki C; Bielec M
    Arch Geschwulstforsch; 1976; 46(6):471-7. PubMed ID: 999456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.